Skip to content
OpenCapital
Get started

Century Therapeutics IPSC Q4 2024 Annual earnings

Reported March 19, 2025 · Before market open

Revenue$4.2MMiss by $45.4MDiluted EPS-$0.43Beat by $0.02
Revenue estimate$49.6M
EPS estimate-$0.45

Next report

Aug 13, 2026 (in a month)
Revenue estimate$2.2M
EPS estimate-$0.11

Versus estimates

Revenue

Q1 2025$109.2MBeat by $67.9M
Q4 2024$4.2MMiss by $45.4M

Diluted EPS

Q1 2026-$0.11Beat by $0.04Q4 2025-$0.25Beat by $0.03Q3 2025-$0.32Beat by $0.07Q2 2025-$0.38In lineQ1 2025$0.89Beat by $1.20
Q4 2024-$0.43Beat by $0.02

Ask the moment Century Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Century Therapeutics report Q4 2024 earnings?
Century Therapeutics (IPSC) reported Q4 2024 earnings on March 19, 2025 before market open.
What were Century Therapeutics's Q4 2024 revenue and EPS?
Century Therapeutics reported revenue of $4.2M and diluted EPS of $-0.43 for Q4 2024.
Did Century Therapeutics beat estimates in Q4 2024?
Revenue missed the consensus estimate of $49.6M by $45.4M. EPS beat the consensus estimate of $-0.45 by $0.02.
Where can I find Century Therapeutics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001558370-25-003299) directly on SEC EDGAR. The filing index links above go to sec.gov.